| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $102,829,558 ) (Continued on the next page) |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | K08NS118138 | Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapy | 000 | 5 | NIH | 8/12/2024 | $157,140 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | P01HD104435 | Utilization of Advanced Technologies for the Understanding of Human Structural Birth Defects | 000 | 4 | NIH | 12/21/2023 | $1,443,563 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01MH135568 | Atypical Development in Infants and Toddlers: Computational Attentional Signatures through Mobile Eye Tracking | 000 | 1 | NIH | 12/7/2023 | $798,405 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DK135211 | Phentermine/Topiramate in children, adolescents, and young adults with hypothalamic obesity: a pilot and feasibility study | 000 | 2 | NIH | 5/27/2024 | $328,635 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01ES025169 | TIDES III: Endocrine Disruption, Hormones, and Sex Differences in Adolescent Airway Health | 000 | 8 | NIH | 6/3/2024 | $1,573,741 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R00MH125328 | The experience of human subjects with brain organoid research | 000 | 5 | NIH | 8/19/2024 | $217,214 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 Sand Point Way NE | Seattle | WA | 98105-3916 | KING | USA | U0333156 | Pediatric Emergency Care Applied Research Network (PECARN) | 00 | 6 | HRSA | 8/29/2024 | $749,969 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R56AR083929 | Comparative effectiveness study of current treatments in children with Chronic Nonbacterial Osteomyelitis (CNO) | 000 | 1 | NIH | 9/13/2024 | $408,031 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R61MH135114 | Integrated movement tracking for pediatric OPM-MEG studies of intellectual disability | 000 | 1 | NIH | 7/8/2024 | $2,031,463 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 002 | 9 | NIH | 6/10/2024 | $0 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 002 | 9 | NIH | 6/10/2024 | $0 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 001 | 9 | NIH | 5/9/2024 | $600,000 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U19AI128914 | Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization | 001 | 9 | NIH | 5/9/2024 | $1,500,000 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R35GM139566 | Volatile Anesthetics and Metabolism Administrative Supplement for Equipment | 002 | 4 | NIH | 9/5/2024 | $123,356 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R35GM139566 | Volatile Anesthetics and Metabolism Administrative Supplement for Equipment | 001 | 4 | NIH | 5/20/2024 | $81,997 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R35GM139566 | Volatile Anesthetics and Metabolism Administrative Supplement for Equipment | 000 | 4 | NIH | 2/6/2024 | $737,978 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R37NS095733 | Pathological Mechanisms of Human Cerebellar Malformations | 001 | 9 | NIH | 6/24/2024 | $764,268 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R61NS137365 | Chemogenetic Mouse Models for Cerebral Hypoperfusion and VCID | 000 | 1 | NIH | 6/17/2024 | $683,367 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R03NS135446 | Brain Tumor CAR T Mouse Model | 000 | 1 | NIH | 1/18/2024 | $98,450 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R21CA292221 | Assessing the efficacy of a ROR1:PD-L1:CD2 multispecific T cell engager in ROR1-positive and -negative neuroblastoma models | 000 | 1 | NIH | 8/23/2024 | $503,194 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | F31EY035932 | Control of retinal cell fate specification by the miR9-2 disease gene locus | 000 | 1 | NIH | 7/19/2024 | $42,574 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HL163103 | Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy | 001 | 2 | NIH | 6/12/2024 | $67,916 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HL163103 | Hexosamine biosynthesis pathway metabolism during cardiac hypertrophy | 000 | 2 | NIH | 11/6/2023 | $764,056 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | F31EY035932 | Control of retinal cell fate specification by the miR9-2 disease gene locus | 002 | 1 | NIH | 9/6/2024 | $0 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI172824 | Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites | 001 | 2 | NIH | 5/23/2024 | $79,231 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI172824 | Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites | 000 | 2 | NIH | 1/12/2024 | $713,088 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | F31EY035932 | Control of retinal cell fate specification by the miR9-2 disease gene locus | 001 | 1 | NIH | 9/6/2024 | $1,594 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R61DA061846 | Multilevel SUD and Overdose Prevention for Rural Youth Involved in County Legal Systems | 000 | 1 | NIH | 9/20/2024 | $1,751,868 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U01DK084575 | Continuation of the Childhood Liver Disease Research Network - Seattle Clinical Center | 001 | 16 | NIH | 6/25/2024 | $300,000 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | UG3OD035508 | Mediators and Modifiers of Prenatal Environmental Exposures and Child Neurodevelopment: DNA methylation, Prenatal Diet, and Cognitive Stimulation (MEND) | 000 | 2 | NIH | 6/12/2024 | $1,417,730 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DE033703 | Leveraging Data for Infants with Cleft to Grow and Flourish: The BLOOM Study | 001 | 1 | NIH | 8/27/2024 | $0 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01DE033703 | Leveraging Data for Infants with Cleft to Grow and Flourish: The BLOOM Study | 000 | 1 | NIH | 7/22/2024 | $815,556 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | K08DK138302 | Epigenetic regulation of kidney regeneration | 000 | 1 | NIH | 7/23/2024 | $154,980 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI177257 | Perturbations of host cell signaling by a complex hepatotropic pathogen | 001 | 12 | NIH | 5/23/2024 | $64,545 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI177257 | Perturbations of host cell signaling by a complex hepatotropic pathogen | 000 | 12 | NIH | 1/16/2024 | $580,903 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | F32GM156113 | Regulation of nervous system health and function by the E3 ligase UBR-1 | 000 | 1 | NIH | 8/5/2024 | $74,284 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U01AI155335 | Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines | 001 | 4 | NIH | 5/24/2024 | $124,220 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | U01AI155335 | Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines | 000 | 4 | NIH | 1/12/2024 | $1,117,978 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI163160 | Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | 001 | 3 | NIH | 5/24/2024 | $86,037 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AI163160 | Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling | 000 | 3 | NIH | 1/4/2024 | $774,338 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 001 | 2 | NIH | 6/28/2024 | $84,013 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01AG081840 | Pericyte control of capillary perfusion in the Alzheimer's disease brain | 000 | 2 | NIH | 1/29/2024 | $756,120 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | UH3DE029753 | Shared Reading Intervention for Children with Oral Clefts | 002 | 4 | NIH | 9/4/2024 | $731,178 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 001 | 2 | NIH | 6/12/2024 | $67,630 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01GM140287 | Haplotype-aware models of gene and isoform expression with application to genetic studies of disease in diverse populations | 007 | 4 | NIH | 5/15/2024 | $72,312 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HD090230 | Optimizing Collaborative Care for Youth with Persistent Post-Concussive Symptoms | 002 | 6 | NIH | 5/3/2024 | $67,542 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01GM140287 | Haplotype-aware models of gene and isoform expression with application to genetic studies of disease in diverse populations | 002 | 4 | NIH | 11/17/2023 | $650,806 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HL166317 | Unraveling a parabrachial circuit for the state-dependent control of rapid breathing | 000 | 2 | NIH | 12/15/2023 | $760,829 |
| | 2024 | 2024 | SEATTLE CHILDREN'S HOSPITAL | 4800 SAND POINT WAY NE | SEATTLE | WA | 98105-3916 | KING | USA | R01HD090230 | Optimizing Collaborative Care for Youth with Persistent Post-Concussive Symptoms | 001 | 6 | NIH | 4/15/2024 | $675,427 |
|
